Moderna’s study shows the ineffectiveness of their shots against the Omicron and why they recommend a booster Moderna scientists published a study Serum Neutralizing Activity of mRNA-1273 Against the SARS-CoV-2 B.1.1.529 (Omicron) Variant: A Preliminary Report that came out yesterday as a preprint in medRxiv. They took blood samples from participants in their phase 2…
Tag: B.1.1.529
Two studies show why the Omicron variant has low fatality and high infectivity
“Out of life’s school of war—what doesn’t kill me, makes me stronger.” – Friedrich Nietzsche, Twilight of the Idols, The mutations in the omicron variant allow it to escape the immune response, but its entry into the lung cells becomes impaired. This explains the higher transmission but lower mortality rates in South Africa. The higher…
Computer model: Natural antibodies still effective on the omicron variant
Research presented in this article answers the question, Are antibodies from natural infection and vaccines effective against the omicron variant? The omicron variant (B1.1.529) has 60 mutations, and fifteen of them are in the receptor-binding domain (RBD). The mutations can change the shape of the RBD and make it unrecognizable to existing antibodies from previous COVID…